Biomedicine Alumni eNews June 2019
Message from the Director of the Monash BDI
It has been an incredibly busy and rewarding time at the Monash BDI and we are brimming with news to share.
A highlight has been the opening of our new Biomedical Learning and Teaching Building. It has almost seen a full semester completed and I am thrilled that our students have quickly and easily transitioned to this state-of-the-art learning space.
Earlier this month, we hosted the first meeting with our International Scientific Advisory Board. This board of nine research luminaries gathered at the Monash BDI, travelling from different corners of the world, to bring fresh insights and perspectives on global trends in discovery science and contribute to our research strategy.
We’ve also had a number of ground-breaking research discoveries and commercial agreements take place, a few of which are highlighted in this newsletter. I encourage you to visit our website to keep up-to-date and be sure to follow me on Twitter (@jcarrollmonash) to join the conversation.
Professor John Carroll
Director, Monash Biomedicine Discovery Institute
Dean, Biomedical Sciences, Monash University
Breakthrough in developing an elusive universal flu vaccine
New research by Monash University and the Doherty Institute creates the potential for the development of a world-first universal, one-shot flu vaccine which would not need to be updated annually.
In this paradigm-shifting discovery, researchers, including Monash BDI’s Professor Tony Purcell, have identified immune cells that can fight all influenza viruses, A, B and C.
Researchers reveal prostate tumours ‘fed’ by fatty acids
An international multidisciplinary study initiated by Melbourne scientists, including Monash BDI’s Deputy Director of Cancer Program, Associate Professor Renea Taylor, has shown a link between the uptake of fatty acids by cancer cells and prostate cancer tumour growth.
The findings point to a possible therapeutic target for this common cancer.
Inosi Therapeutics launched to tackle fibrosis
Inosi Therapeutics has been founded to develop therapies to address fibrosis, a condition associated with many chronic diseases where tissue damage leads to scarring and loss of function.
The establishment of this company enables early engagement and collaboration between academic researchers and industry partners to ensure new therapy development programs address unmet patient and market needs.
Transforming cell therapy
Cell Mogrify, co-founded by Monash BDI researcher Professor Jose Polo, promises to develop novel lifesaving cell therapies. This company has attracted additional seed funding from major investors, bringing it one step closer to commercialising ground-breaking cell therapy research.
Maximising the Monash BDI’s future global research impact and strategy
Monash BDI has established an International Scientific Advisory Board (ISAB) to provide strategic counsel to our Executive Committee and further develop our research strategy.
The ISAB is comprised of nine international luminaries in the field of medical research. It convened for the first time early in May here at the Monash BDI in Clayton
Biomedicine alumni having large scale social impact with startup Ally Assist
Two Monash biomedicine alumni, Sam Donegan (BBiomedSci 2012) and Nikita Fernandes (BBiomedSci 2016), have translated their skills to form successful social startup organisation, Ally Assist.
With support from the university’s Generator Startup Accelerator program, this alumni-founded startup supports individuals and families living with disability and helps build independence.
Find out more about Ally Assist and the Generator program.
Do you want to get more involved with the Monash BDI?
There are a range of opportunities you could get involved in as an alumni, such as sharing your story, becoming a mentor, registering as a guest speaker, and more.
Let us know which of these activities appeal to you. This will help make your experience with us more tailored, relevant and rewarding for you.
Reconnect with the Monash BDI community through these enriching experiences and make a difference by inspiring and supporting the next generation of biomedicine alumni.